Fusion
THERAPEUTIC AREA
Oncology
YEAR INVESTED
2019
STAGE
IPO’d in 2020; acquired by AstraZeneca in 2024
WEBSITE
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines.
